← Leaderboards
Devendra K. Agrawal
Creighton University
$29,850,940
Attributed
$29,850,940
Total exposure
13
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,850,940 · 13
By mechanism
R01$29,471,860 · 12
R25$379,080 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineInflammatoryPreventHyperplasiaCellsBlood VesselsInvestigationSmooth Muscle MyocytesInflammationFamily SuidaeStenosisTnf GeneCoronary ArteriosclerosisFunctional DisorderUlcerMolecularApoptosisAtherosclerosisRestenosisCaliberCell ProliferationLipidsThickPathology
Grant awards (66)
Research Education Program to Promote Diversity in Immunologic and Allergic Diseases$379,080
R25 · FY2025 · AI · contact PI
Novel Molecular Target to Prevent Maturation Failure of Arteriovenous Fistula$704,979
R01 · FY2022 · HL · contact PI
Novel Molecular Target to Prevent Maturation Failure of Arteriovenous Fistula$704,979
R01 · FY2021 · HL · contact PI
Novel Approach to Stabilize Atherosclerotic Plaque in Carotid Artery$674,605
R01 · FY2021 · HL · contact PI
Novel Molecular Target to Prevent Maturation Failure of Arteriovenous Fistula$704,979
R01 · FY2020 · HL · contact PI
Novel Approach to Stabilize Atherosclerotic Plaque in Carotid Artery$690,240
R01 · FY2020 · HL · contact PI
Novel Molecular Target to Prevent Maturation Failure of Arteriovenous Fistula$704,979
R01 · FY2019 · HL · contact PI
Novel Approach to Stabilize Atherosclerotic Plaque in Carotid Artery$588,912
R01 · FY2019 · HL · contact PI
Novel Approach to Stabilize Atherosclerotic Plaque in Carotid Artery$136,396
R01 · FY2019 · HL · contact PI
Novel Approach to Stabilize Atherosclerotic Plaque in Carotid Artery$30,490
R01 · FY2019 · HL · contact PI
Novel Approach to Stabilize Atherosclerotic Plaque in Carotid Artery$727,485
R01 · FY2018 · HL · contact PI
GENE AND STEM CELL THERAPY IN CORONARY ARTERY BYPASS GRAFT$725,815
R01 · FY2018 · HL · contact PI
GENE AND STEM CELL THERAPY IN CORONARY ARTERY BYPASS GRAFT$725,815
R01 · FY2017 · HL · contact PI
EPICARDIAL ADIPOSE TISSUE, OBESITY AND INFLAMMATION IN ATHEROSCLEROSIS$710,152
R01 · FY2017 · HL · contact PI
MESENCHYMAL STEM CELLS IN THE PREVENTION OF THROMBOSIS AND NEOINTIMAL HYPERPLASIA$767,348
R01 · FY2016 · HL · contact PI
GENE AND STEM CELL THERAPY IN CORONARY ARTERY BYPASS GRAFT$725,815
R01 · FY2016 · HL · contact PI
EPICARDIAL ADIPOSE TISSUE, OBESITY AND INFLAMMATION IN ATHEROSCLEROSIS$710,152
R01 · FY2016 · HL · contact PI
VITAMIN D AND IMMUNOMODULATION IN CORONARY ARTERY DISEASE$624,257
R01 · FY2016 · HL · contact PI
MESENCHYMAL STEM CELLS IN THE PREVENTION OF THROMBOSIS AND NEOINTIMAL HYPERPLASIA$794,879
R01 · FY2015 · HL · contact PI
EPICARDIAL ADIPOSE TISSUE, OBESITY AND INFLAMMATION IN ATHEROSCLEROSIS$729,975
R01 · FY2015 · HL · contact PI
GENE AND STEM CELL THERAPY IN CORONARY ARTERY BYPASS GRAFT$725,815
R01 · FY2015 · HL · contact PI
VITAMIN D AND IMMUNOMODULATION IN CORONARY ARTERY DISEASE$684,894
R01 · FY2015 · HL · contact PI
MESENCHYMAL STEM CELLS IN THE PREVENTION OF THROMBOSIS AND NEOINTIMAL HYPERPLASIA$779,682
R01 · FY2014 · HL · contact PI
EPICARDIAL ADIPOSE TISSUE, OBESITY AND INFLAMMATION IN ATHEROSCLEROSIS$751,549
R01 · FY2014 · HL · contact PI
VITAMIN D AND IMMUNOMODULATION IN CORONARY ARTERY DISEASE$681,771
R01 · FY2014 · HL · contact PI
GENE THERAPY WITH SOCS-3 IN INTIMAL HYPERPLASIA AND IN-STENT RESTENOSIS$602,590
R01 · FY2014 · HL · contact PI
EPICARDIAL ADIPOSE TISSUE, OBESITY AND INFLAMMATION IN ATHEROSCLEROSIS$25,797
R01 · FY2014 · HL · contact PI
EPICARDIAL ADIPOSE TISSUE, OBESITY AND INFLAMMATION IN ATHEROSCLEROSIS$676,067
R01 · FY2013 · HL · contact PI
MESENCHYMAL STEM CELLS IN THE PREVENTION OF THROMBOSIS AND NEOINTIMAL HYPERPLASIA$669,734
R01 · FY2013 · HL · contact PI
VITAMIN D AND IMMUNOMODULATION IN CORONARY ARTERY DISEASE$594,294
R01 · FY2013 · HL · contact PI
GENE THERAPY WITH SOCS-3 IN INTIMAL HYPERPLASIA AND IN-STENT RESTENOSIS$587,008
R01 · FY2013 · HL · contact PI
APOPTOSIS OF SMOOTH MUSCLE CELLS IN CAROTID PLAQUES$306,424
R01 · FY2013 · HL · contact PI
VITAMIN D AND IMMUNOMODULATION IN CORONARY ARTERY DISEASE$70,000
R01 · FY2013 · HL · contact PI
MESENCHYMAL STEM CELLS IN THE PREVENTION OF THROMBOSIS AND NEOINTIMAL HYPERPLASIA$54,429
R01 · FY2013 · HL · contact PI
MESENCHYMAL STEM CELLS IN THE PREVENTION OF THROMBOSIS AND NEOINTIMAL HYPERPLASIA$636,771
R01 · FY2012 · HL · contact PI
VITAMIN D AND IMMUNOMODULATION IN CORONARY ARTERY DISEASE$624,257
R01 · FY2012 · HL · contact PI
GENE THERAPY WITH SOCS-3 IN INTIMAL HYPERPLASIA AND IN-STENT RESTENOSIS$618,355
R01 · FY2012 · HL · contact PI
SMOOTH MUSCLE CELL PROLIFERATION IN HUMAN CORONARY ARTERY BYPASS GRAFTS$357,638
R01 · FY2012 · HL · contact PI
TGF-BETA, CHLORIDE CHANNELS AND MIGRATION OF EOSINOPHILS$351,611
R01 · FY2012 · AI · contact PI
APOPTOSIS OF SMOOTH MUSCLE CELLS IN CAROTID PLAQUES$321,874
R01 · FY2012 · HL · contact PI
MESENCHYMAL STEM CELLS IN THE PREVENTION OF THROMBOSIS AND NEOINTIMAL HYPERPLASIA$51,255
R01 · FY2012 · HL · contact PI
GENE THERAPY WITH SOCS-3 IN INTIMAL HYPERPLASIA AND IN-STENT RESTENOSIS$620,139
R01 · FY2011 · HL · contact PI
SMOOTH MUSCLE CELL PROLIFERATION IN HUMAN CORONARY ARTERY BYPASS GRAFTS$361,250
R01 · FY2011 · HL · contact PI
TGF-BETA, CHLORIDE CHANNELS AND MIGRATION OF EOSINOPHILS$351,611
R01 · FY2011 · AI · contact PI
APOPTOSIS OF SMOOTH MUSCLE CELLS IN CAROTID PLAQUES$325,125
R01 · FY2011 · HL · contact PI
TGF-BETA, CHLORIDE CHANNELS AND APOPTOSIS OF AIRWAY EPITHELIAL CELLS$421,236
R01 · FY2010 · HL · contact PI
SMOOTH MUSCLE CELL PROLIFERATION IN HUMAN CORONARY ARTERY BYPASS GRAFTS$361,250
R01 · FY2010 · HL · contact PI
TGF-BETA, CHLORIDE CHANNELS AND MIGRATION OF EOSINOPHILS$355,163
R01 · FY2010 · AI · contact PI
APOPTOSIS OF SMOOTH MUSCLE CELLS IN CAROTID PLAQUES$325,125
R01 · FY2010 · HL · contact PI
TGF-BETA, CHLORIDE CHANNELS AND APOPTOSIS OF AIRWAY EPITHELIAL CELLS$453,254
R01 · FY2009 · HL · contact PI
SMOOTH MUSCLE CELL PROLIFERATION IN HUMAN CORONARY ARTERY BYPASS GRAFTS$361,250
R01 · FY2009 · HL · contact PI
TGF-BETA, CHLORIDE CHANNELS AND MIGRATION OF EOSINOPHILS$358,750
R01 · FY2009 · AI · contact PI
TGF-BETA, CHLORIDE CHANNELS AND MIGRATION OF EOSINOPHILS$358,750
R01 · FY2008 · AI · contact PI
APOPTOSIS OF SMOOTH MUSCLE CELLS IN CAROTID PLAQUES$248,366
R01 · FY2008 · HL · contact PI
FLT3-LIGAND, IMMUNOMODULATION AND THERAPY IN ASTHMA$22,960
R01 · FY2008 · HL · contact PI
APOPTOSIS OF SMOOTH MUSCLE CELLS IN CAROTID PLAQUES$12,054
R01 · FY2008 · HL · contact PI
APOPTOSIS OF SMOOTH MUSCLE CELLS IN CAROTID PLAQUES$276,987
R01 · FY2007 · HL · contact PI
FLT3-LIGAND, IMMUNOMODULATION AND THERAPY IN ASTHMA$255,269
R01 · FY2007 · HL · contact PI
APOPTOSIS OF SMOOTH MUSCLE CELLS IN CAROTID PLAQUES$285,260
R01 · FY2006 · HL · contact PI
FLT3-LIGAND, IMMUNOMODULATION AND THERAPY IN ASTHMA$263,544
R01 · FY2006 · HL · contact PI
FLT3-LIGAND, IMMUNOMODULATION AND THERAPY IN ASTHMA$270,533
R01 · FY2005 · HL
APOPTOSIS OF SMOOTH MUSCLE CELLS IN CAROTID PLAQUES$249,375
R01 · FY2005 · HL
APOPTOSIS OF SMOOTH MUSCLE CELLS IN CAROTID PLAQUES$42,750
R01 · FY2005 · HL
FLT3-LIGAND, IMMUNOMODULATION AND THERAPY IN ASTHMA$267,042
R01 · FY2004 · HL
APOPTOSIS OF SMOOTH MUSCLE CELLS IN CAROTID PLAQUES$249,375
R01 · FY2004 · HL
FLT3-LIGAND, IMMUNOMODULATION AND THERAPY IN ASTHMA$21,375
R01 · FY2004 · HL